Paper1596901
Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.
Edwards MJ and 5 others. Cancer Res, 1992. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Papers, record 1596901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1596901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Capillary Permeability | Major topic |
| Endothelium, Vascular | Major topic |
| Interleukin-2 | Major topic |
| Neutrophils | Major topic |
| Platelet Adhesiveness | Major topic |
| Administration, Topical | |
| Animals | |
| Cell Adhesion | |
| Injections, Intravenous | |
| Male | |
| Microcirculation | |
| Microscopy, Electron | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40139976 | Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data. | Immunohorizons | 2025 | https://conductscience.org/library/papers/40139976 | PubMed |
| 39852848 | Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/39852848 | PubMed |
| 35360982 | The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. | Clin Appl Thromb Hemost | 2022 | https://conductscience.org/library/papers/35360982 | PubMed |
| 31073219 | Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials. | Sci Rep | 2019 | https://conductscience.org/library/papers/31073219 | PubMed |
| 28545888 | Delivering safer immunotherapies for cancer. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28545888 | PubMed |
| 24179731 | Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. | Am J Clin Exp Immunol | 2013 | https://conductscience.org/library/papers/24179731 | PubMed |
| 21668966 | Acute exhaustive exercise regulates IL-2, IL-4 and MyoD in skeletal muscle but not adipose tissue in rats. | Lipids Health Dis | 2011 | https://conductscience.org/library/papers/21668966 | PubMed |
| 15627211 | Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15627211 | PubMed |
| 8872500 | Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. | Inflammation | 1996 | https://conductscience.org/library/papers/8872500 | PubMed |
| 7842289 | Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs. | Ann Surg Oncol | 1994 | https://conductscience.org/library/papers/7842289 | PubMed |
| 7712595 | Eicosanoids and the immunology of cancer. | Cancer Metastasis Rev | 1994 | https://conductscience.org/library/papers/7712595 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1596901
GET https://conductscience.org/api/papers/v1/1596901/authors